A RANDOMIZED PHASE II TRIAL OF VELIPARIB (V), RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN PATIENTS (PTS) WITH UNMETHYLATED MGMT (uMGMT) GLIOBLASTOMA (GBM): THE VERTU STUDY

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Khasraw, M; McDonald, KL; Rosenthal, M; Lwin, Z; Ashley, D; Wheeler, H; Barnes, E; Foote, M; Koh, E-S; Sulman, E; Back, M; Buckland, M; Sim, H-W; Fisher, L; Leonard, R; Hall, M; Yip, S; Simes, J

Published Date

  • November 1, 2019

Published In

Volume / Issue

  • 21 /

Start / End Page

  • 18 - 18

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1523-5866

International Standard Serial Number (ISSN)

  • 1522-8517

Conference Name

  • 24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS

Conference Location

  • Phoenix, AZ

Conference Start Date

  • November 20, 2019

Conference End Date

  • November 24, 2019